Recent Posts

  1. cafead

    Abbott Has a Powerful Product Lineup in the Chamber

    via For the first time since 2016, Abbott raised its organic sales guidance for the year during the first quarter. The company now expects to achieve organic sales growth between 8.5% and 10% over last year, excluding COVID testing. “And medical...

  2. cafead

    How Vir found the one: CEO Marianne De Backer

    via Vir Biotechnology conducted a world-wide search to find the perfect CEO. In the end, the board picked Bayer’s Marianne De Backer, Ph.D., because of her three decades of experience in the pharmaceutical industry and her “deep and thorough...

  3. cafead

    Histogen Files for Voluntary Chapter 11 Protection to Facilitate Wind-Down, Maximize Share...

    via Histogen Inc. (HSTO, the “Company” or “Histogen”), a drug development company for treatment of bacterial skin infections, today announced that it has filed voluntary petitions for relief under subchapter V of Chapter 11 of the U.S. Bankruptcy...

  4. cafead

    Alvotech, Teva Enlist New Partner to Expand Access to Humira Biosimilar in US

    via Alvotech and Teva Pharmaceuticals on Friday announced that they have signed a new long-term agreement with an undisclosed strategic partner in order to make its Humira biosimilar Simlandi (adalimumab-ryvk) more accessible to U.S. patients....

  5. cafead

    AstraZeneca’s Tagrisso maintains momentum in NSCLC with FLAURA2 results

    via Lung cancer is the leading cause of cancer death around the world, with an estimated 2.2 million new cases and 1.8 million lung cancer-related deaths per year. Non-small cell lung cancer (NSCLC) constitutes around 85% of lung cancer cases,...

  6. anonymous

    Only CV1 allowed to adjust call plan?

    Great perspective, some of the leadership should be ashamed of themselves and admit they’re in over their head. Reps are expendable, never people first. It’s just business. As soon as des says technology will make you happy and healthy and my...

  7. anonymous

    Phathom

    The letter to shareholders indicates they want to expand into the gi space potentially

  8. + Show More

  1. General Discussion

    Discussion boards of general interest for those in the pharma, biotech, medical device, and related industries
  2. Pharma/Biotech Companies

    Anonymous discussion boards for pharmaceutical and biotech companies
  3. Regional Discussion and Job Opportunities

    Discussion and job opportunities by region
  4. Lost Civilizations

    Anonymous discussion boards for pharma/medical companies that no longer exist due to acquisition or other factors
  5. Laboratory/Diagnostic Sales

    Anonymous discussion boards for lab sales/diagnostics companies
  6. Animal Health Sales

    Anonymous discussion boards for animal health companies
  7. Medical Equipment/Device Sales

    Anonymous discussion boards for medical equipment/device companies
  8. Pharmacies

    Anonymous boards for pharmacy employees
  9. PBMs

    Anonymous discussion boards for PBMs
  10. Pharma/Healthcare Marketing Agencies

    Anonymous discussion boards for pharma/healthcare marketing agencies
  11. Dental Reps

    Anonymous discussion boards for dental health companies
  12. Managed Care Specialists

    Anonymous discussion boards for managed care specialists
  13. Pharma IT

    Anonymous discussion boards for pharma IT employees

Forum Statistics

Discussions:
206,007
Messages:
2,749,668
Members:
6,069
Latest Member:
S R W